Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of DiaPep277 in newly diagnosed type 1 diabetes
2009-015929-37Phase 3Completed
- Sponsor
- Andromeda Biotech Ltd.
- Start
- Jun 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing DiaPep277 with Placebo (2 arms). Primary endpoint: Change from baseline in GST C-peptide AUC0-20min at 24 months. Started Jun 2010; status: completed.
02
Drugs
diapep277
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2009-015929-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015929-37.